Abstract: Provided are a method of creating an index for blockchain data and a device and method for searching for blockchain data. The method of creating an index for blockchain data includes receiving, by a blockchain data search device, data to be stored in a blockchain network from a user application, requesting, by the blockchain data search device, the blockchain network to store the data and receiving a block number of a block in which the data is stored and a transaction identifier (ID) from the blockchain network when storage of the data is completed, and encrypting, by the blockchain data search device, the data and creating an index for the data on the basis of the encrypted data, the block number, and the transaction ID.

Abstract: The present invention relates to a novel strain having the activity of reducing advanced glycation end products and a use thereof and, more particularly, to a food composition having the activity of reducing advanced glycation end products and a pharmaceutical composition for preventing or treating a disease caused by advanced glycation end products each of which comprises a Lactococcus lactis KF140 (accession number KCCM11673P) strain, a Bacillus subtilis KF11 (accession number KCCM11981P) strain, a Lactobacillus pentosus KF8 (accession number KCCM11997P) strain, or a Lactobacillus paracasei KF00816 (accession number KCCM11998P) strain, which are all novel strains; a lysate thereof; or a culture thereof as an active ingredient.

Abstract: A display device includes a display panel including sub-pixels, a display panel driver configured to control the display panel, a touch panel including a touch sensor including a plurality of touch electrodes and a charger including a plurality of charge electrodes, and a touch panel driver configured to provide a first charge voltage having a first phase to N first charge electrodes among the charge electrodes in a first charge period, and provide the first charge voltage to M (M is different from N) second charge electrode among the charge electrodes in a second charge period.

Abstract: A touch sensor includes a sensing electrode that receives a touch input disposed on a sensing area of a substrate; and a plurality of sensing lines disposed on a non-sensing area of the substrate. Each of the plurality of sensing lines includes a first area and a second area, and first and second metal layers electrically coupled to the sensing electrode. The second metal layer is disposed on the first metal layer, and an insulating layer is interposed between the first and second metal layers. The sensing lines include first and second sensing lines. The first and second sensing lines include the first and second metal layers in the first area. The first sensing line includes the first metal layer without the second metal layer in the second area, and the second sensing line includes the second metal layer without the first metal layer in the second area.

Abstract: A peptide fragment for treatment of cancer, a variant thereof, and a use thereof. A peptide fragment of VGLL1 and/or a variant thereof inhibits the proliferation and invasion of cancer cells, thereby exhibiting an excellent effect on the prevention and treatment of cancer.

Abstract: An inhaler includes a housing having one surface, the other surface opposite to the one surface, and a plurality of side surfaces connecting the one surface and the other surface, a mouthpiece which is disposed on the one side of the housing, a reservoir which is disposed inside the housing and stores an inhalable composition, a nozzle which extends from the mouthpiece to the reservoir, and a needle valve which is movably disposed inside the nozzle, when a suction force is not applied to the mouthpiece, the needle valve is maintained in a first state in which the nozzle is closed, and when a suction force is applied through the mouthpiece, the needle valve is switched into a second state in which the nozzle is opened.

Abstract: A display device includes: a substrate; a first pixel electrode and a second pixel electrode on the substrate; a dummy pixel electrode between the first pixel electrode and the second pixel electrode, and to receive a dummy voltage; an emissive layer on the first pixel electrode, the second pixel electrode, and the dummy pixel electrode; and a common electrode on the emissive layer. The first pixel electrode is to receive a pixel voltage different from the dummy voltage.

Abstract: A pharmaceutical composition, an oral administration agent and an eye drop for preventing or treating retinal diseases or optic nerve diseases including the compound represented by the Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient and the pharmaceutical composition, the oral administration agent and the eye drop can effectively prevent or treat retinal disease or optic nerve disease.

Abstract: A dishwasher according to one embodiment may comprise a storage part for storing an object to be washed. The storage part comprises: a base in which a plurality of horizontal bars and a plurality of vertical bars intersect each other; a supporter protruding from the base; and a first holder mounted to the supporter and provided so as to be rotatable with respect to the supporter, wherein the first holder may be supported by the supporter so as to maintain a posture at a set angle with respect to the supporter.

Abstract: A substrate transferring apparatus includes a support plate including an upper surface on which a substrate is configured to be seated, and a vacuum pad detachably coupled to the support plate and configured to vacuum suction the substrate to fix the substrate on the upper surface of the support plate, wherein the vacuum pad includes a suction area and a support protrusion surrounding the suction area, an upper surface of the support protrusion is at a higher vertical level than an upper surface of the suction area to support the substrate, and the upper surface of the support protrusion is inclined relative to horizontal.

Abstract: A new use of M-CSF or G-CSF for diagnosis or treatment of pulmonary fibrosis is disclosed. A marker for diagnosing the level of development or progression of pulmonary fibrosis contains M-CSF and/or G-CSF; and a composition for preventing or treating pulmonary fibrosis, contains an M-CSF inhibitor and a G-CSF inhibitor as active ingredients. The present inventors have ascertained that M-CSF and/or G-CSF is a marker for development or progression of pulmonary fibrosis, and have confirmed that a composition, which contains M-CSF and G-CSF and which binds to M-CSF and G-CSF so that the inherent mechanism thereof can be prevented, has an effect of significantly inhibiting myofibroblast hyperplasia or pulmonary fibrosis of the pulmonary cells, and thus the marker and the composition of the present disclosure are expected to be effectively usable for diagnosis, prevention or treatment of pulmonary fibrosis.

Abstract: The present disclosure relates to a cell-penetrating peptide, an anticancer peptide, and a pharmaceutical composition for preventing or treating cancer including the same. The cell-penetrating peptide of the present disclosure can further improve a cancer cell growth inhibitory effect of anticancer peptides, especially cancer therapeutic peptides with improved anticancer activity by cyclic structures, and thus can be effectively applied to the prevention or treatment of various cancers.

Abstract: A white light emitting device and a display device using the same which can prevent a change in luminance due to change in viewing angle, improve color deviation, and lower a driving voltage at the same time, through a change in an internal stack structure and a thickness an emission-side electrode with regard to a vertical distance from a lower surface of the first electrode to a lower surface of the second electrode.

Abstract: Disclosed is a silver powder preparation method including a silver salt reduction step. The silver salt reduction step includes a reaction solution preparation step for preparing a first reaction solution and a second reaction solution and a precipitation step for allowing reaction between the first reaction solution and the second reaction solution to precipitate silver particles. The first reaction solution contains silver ions, ammonia, an alkali metal salt of an organic acid, and a phosphorous compound, and the second reaction solution contains a reducing agent. The content of the phosphorous compound and the reaction temperature of the precipitation step are adjusted so that the shrinkage rate of the silver powder is adjusted within a range of 5% to 20% at 500° C. when the reaction temperature is heated to 800° C. at a heating rate of 50° C./min.

Abstract: An oxide semiconductor thin film transistor and a method of forming the oxide semiconductor thin film transistor are provided. The oxide semiconductor thin film transistor can include a semiconductor layer including a channel region, a source region and a drain region; a first gate insulating layer on the semiconductor layer; a gate electrode on the first gate insulating layer; a second gate insulating layer on the gate electrode; an auxiliary electrode on the second gate insulating layer; an interlayer insulating layer on the auxiliary electrode; and a source electrode and a drain electrode on the interlayer insulating layer, wherein the source region and the drain region being disposed at both sides of the channel region, wherein the gate electrode overlapping with the channel region, and the auxiliary electrode overlapping with the gate electrode.

Abstract: The present invention relates to a prebiotic composition, a composition for improving gut microorganisms, a composition for improving gut health or gut function, a composition for alleviating, preventing, or treating inflammatory bowel disease or leaky gut syndrome, or a composition for alleviating, preventing, or treating obesity or metabolic disease, which each comprise a molokhia extract or a molokhia polymer fraction as an active ingredient to induce the proliferation of beneficial intestinal bacteria and to improve, prevent, or treat gut heath or gut function. In addition, the composition comprising a molokhia extract or a molokhia polymer fraction as an active ingredient can alleviate, prevent, or treat bowel disease or leaky gut syndrome.

Abstract: The present disclosure relates to a pharmaceutical composition, an oral administration agent and an eye drop for preventing or treating retinal diseases or optic nerve diseases including the compound represented by the Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient and the pharmaceutical composition, the oral administration agent and the eye drop can effectively prevent or treat retinal disease or optic nerve disease.